|Last Price$35.75||Day Change (%)-0.86%|
|Open Price$36.06||Day Change ($)-0.31|
|Day Range34.78–37.02||52-Week Range19.71–42.96|
As of Wed 12/18/2013 04:51 PM EST | USD
Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share. The company continues to make progress in each of its programs, namely the addition of a second Phase IIb compound in the Beyond Advair trials and completion ...